Key Record Dates Identifier: NCT02056080
Brief Title: Clinical Benefit of the Treatment With Trastuzumab in Combination With Lapatinib in Metastatic Breast Cancer HER2 Positive Patients Who Has Been Previously Treated With Trastuzumab and/or Lapatinib (TRASTYVERE)

First Submitted : January 10, 2014
First Submitted that Met QC Criteria : February 4, 2014
First Posted : February 5, 2014 (Estimate)

Last Update Submitted that Met QC Criteria : September 6, 2019
Last Update Posted : September 9, 2019